Browsing by Author "Regadas, I"
Now showing 1 - 1 of 1
Results Per Page
Sort Options
- Intravitreal bevacizumab in aggressive posterior retinopathy of prematurityPublication . Travassos, A; Teixeira, S; Ferreira, P; Regadas, I; Travassos, AS; Esperancinha, F; Prieto, I; Pires, G; van Velze, R; Valido, A; Machado, MCThe anatomic response to intravitreal bevacizumab injection in three patients with aggressive, posterior retinopathy of prematurity is described. In all cases, the worse eye was treated with a single intravitreal injection of 0.75 mg of bevacizumab as monotherapy or complementary to laser therapy. In 24 hours, all injected eyes showed regression of the tunica vasculosa lentis and iris vessel engorgement and disappearance of iris rigidity. In addition, plus disease and retinal proliferation began to regress. None of the eyes required additional treatment. Follow-up of up to 10 months showed good anatomic outcomes and no evidence of local or systemic adverse events.